Is it safe?
Can HROW take a bad year?
Harrow, Inc. carries $205M of net debt at 9.66× EBITDA: a heavy load to carry through a bad year.
$205M
Net debt · as at Q1 2026 · over four years of earnings before interest, tax and depreciation, heavy
- Net debt / EBITDA
- 9.66×
Net debt / EBITDA · 48.9× a year ago · the load is coming down
- Altman Z-score
- 3.40
Altman Z-score · safe zone, above 3
- Interest cover
- 0.85×
Interest cover · operating profit barely covers the interest bill
Details›
- Total debtQ1 2026
- $300M
- Cash and short-term investments
- $95M
- Net debt
- $205M
- EBITDA, trailing twelve months
- $21M
- Operating profit, trailing twelve months
- $20M
- Debt / equity
- 10.5×
- Total debt / EBITDA
- 14.1×
- Annualised volatilitytwo years of daily moves
- 74%
- Worst drawdown on file
- −71%
- Below its 52-week high
- −28%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Drug Manufacturers - Specialty & Generic
Ranks #26 of 28 by Smart Score